BIOMAT Database Logo BIOMAT Database Logo

[Hormonally active adrenocortical carcinoma and its porphyrin content]. 1978

E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik

UI MeSH Term Description Entries
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000306 Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. Adrenocortical Cancer,Cancer of Adrenal Cortex,Adrenal Cortex Cancer,Cancer of the Adrenal Cortex,Neoplasms, Adrenal Cortex,Adrenal Cortex Cancers,Adrenal Cortex Neoplasm,Adrenocortical Cancers,Cancer, Adrenal Cortex,Cancer, Adrenocortical,Cancers, Adrenal Cortex,Cancers, Adrenocortical,Neoplasm, Adrenal Cortex
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Hormonally inactive adrenocortical carcinoma].
January 1977, Polski przeglad radiologii i medycyny nuklearnej,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Adrenocortical tumor, hormonally active, treated with o,p'DDD and hormonally inactive treated surgically].
June 1980, Polski tygodnik lekarski (Warsaw, Poland : 1960),
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Radiographic findings in a metastasizing hormonally active adrenocortical neoplasms].
November 1973, Der Radiologe,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Ultrastructural criteria of clinical prognosis in hormonally non-active adrenocortical tumors].
January 2003, Voprosy onkologii,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Malignant hormonally inactive adrenocortical tumor].
January 1987, Arkhiv patologii,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Hormonally inactive adrenocortical carcinoma with a 6-year survival following radical surgery].
April 1976, Polski przeglad chirurgiczny,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Adrenocortical carcinoma and its treatment].
February 2004, Postepy higieny i medycyny doswiadczalnej (Online),
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Hormonally active peptides].
March 1998, Ceskoslovenska fysiologie,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
[Hormonally active pheochromocytoma].
January 1982, Khirurgiia,
E Szklarz, and B Zawirska, and S Gruszka, and Z Plamieniak, and W Wrezlewicz, and L Moszczyński, and T Dzik
Atypical presentation of a hormonally active adrenocortical tumor in an adolescent leading to delayed diagnosis.
January 2011, Hormones (Athens, Greece),
Copied contents to your clipboard!